# A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Study · id `cardio:ct-nct06825416` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06825416](<https://clinicaltrials.gov/study/NCT06825416>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06825416

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1165 participants.

## Technical summary

Registry record NCT06825416. Randomized; quadruple masking; primary purpose prevention. Start 2025-03-16 (actual); primary completion 2026-02-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1165 participants (enrolled count; ClinicalTrials.gov record NCT06825416, source copy `cardio:ctgov-nct06825416-2026-08-28`, retrieved 2026-10-31)
- Started: 2025-03-16 (actual) (ClinicalTrials.gov record NCT06825416, source copy `cardio:ctgov-nct06825416-2026-08-28`, retrieved 2026-10-31)
- Primary completion: 2026-02-15 (actual) (ClinicalTrials.gov record NCT06825416, source copy `cardio:ctgov-nct06825416-2026-08-28`, retrieved 2026-10-31)
- Completion: 2026-04-23 (actual) (ClinicalTrials.gov record NCT06825416, source copy `cardio:ctgov-nct06825416-2026-08-28`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06825416, source copy `cardio:ctgov-nct06825416-2026-08-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06825416-2026-08-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
- Condition: Prevention of Arterial and Venous Thrombosis
- Intervention (Drug): SHR-2004 injection
- Intervention (Drug): SHR-2004 injection
- Intervention (Drug): Enoxaparin sodium injection
- Intervention (Drug): Enoxaparin sodium injection placebo
- Intervention (Drug): SHR-2004 placebo
- Intervention (Drug): SHR-2004 placebo
- Lead sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry lists this organization as the lead sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd (`cardio:org-beijing-suncadia-pharmaceuticals-co-ltd`)

## Provenance

Content hash: 13d0c3c91eaf83cd9260839ff5818c23a280791eb27a64ccd23fc705b136ee64
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
